The Spring Hill plant is part of the Ultium Cells LLC joint venture between GM and battery supplier LG Energy Solution. A ...

The potential for these kinds of machines to reshape computer processing, increase energy efficiency, and revolutionize ...

Review question: Does the use of animal derived surfactant preparations compared to synthetic surfactant preparations that do not contain protein lead to improved outcome in infants at risk for or ...

In a mouse model of glioblastoma that mimics the pathology and immunological barriers seen in human patients, the targeted cytokines rescued the activity of CAR-T cells that, given alone, were ...

Dr. Matthew Ku discusses what CAR T-cell therapy is and how it works to target diseases like myelofibrosis.

Using xenograft models of lymphoma and leukaemia in NSG mice, they observed that both IFN-γKO and IFN-γRKO CAR-T cells had similar antitumour effects compared with control CAR-T cells.

Current approved CAR T-cell therapy treatments rely on an ex vivo route, in which a patient’s T cells are removed, genetically engineered to target antigens, and put back into the patient.

Using CD34 lineage-tracing mice and single-cell RNA sequencing, we identified a Tfh cell population derived from CD34-lineage CD4 + T cells. Untargeted and targeted metabolomics revealed distinct ...

Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted ...